Wire · opportunities
Beckman Coulter Diagnostics Receives U.S. FDA Clearance for Rapid Bacterial vs. Viral ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 3 November 2026 · Fusion42 review
Beckman Coulter Diagnostics received FDA clearance for the Access MeMed BV assay, a rapid blood test differentiating bacterial from viral infections in adults and children, providing results in as little as 15 minutes. The assay integrates with existing hospital analyzers, supports better treatment decisions, and aims to reduce unnecessary antibiotic use and healthcare costs.
This Wire brief sits within Fusion42's coverage of Medtech, and 6 sources have reported it between 3 Nov 2026 and 4 Nov 2026.
◆ ◆ The Wire takeaway
Rapid bacterial vs viral tests now get results in a quarter hour on existing hospital machines, letting you speed up treatment decisions and cut antibiotic misuse. You can tap into clinical demand for faster diagnostics by linking your product to familiar lab analyzers.
◆ Coverage
6 sources · first reported 3 Nov 2026 · latest 4 Nov 2026
◆ Related on Wire
◆ Topics